Where Insmed Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Insmed (NASDAQ:INSM) stock. The average price target for Insmed has increased by 8.57% from the previous average price target of $45.50 to $49.4. The majority of the ratings are bullish.

September 06, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Insmed has received mostly bullish ratings from analysts over the past 3 months, which has led to an increase in the average price target.
Analyst ratings can significantly influence a stock's price. In the case of Insmed, the majority of the ratings over the past 3 months have been bullish, which has led to an increase in the average price target. This suggests that analysts believe the stock has potential for growth, which could attract more investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100